Ask the Doctor: What is minimal residual disease (MRD)?
Krish Patel, MD of the Swedish Cancer Institute discusses how MRD is measured and what patients should know about testing for it.
Krish Patel, MD of the Swedish Cancer Institute discusses how MRD is measured and what patients should know about testing for it.

LRF grantee Jason Romancik, MD of the Winship Cancer Institute discusses these treatment options and what factors patients should consider when deciding what's right for them.

LRF grantee Natalie Grover, MD of The University of North Carolina at Chapel Hill discusses the evolution of treatments in the past several years and the effect it has had on patients diagnosed with HL.
LRF grantee Christina Lee, MD of the Memorial Sloan Kettering Cancer Center discusses the oral therapies that are currently under investigation for the treatment of frontline MCL and how this could help improve the treatment landscape for these patients.

People who have compromised immune systems may benefit from an additional dose to make sure they have enough protection against COVID-19.
Foundation to celebrate achievements of world-renowned hematologist and oncologist Christopher Flowers, MD and corporate patient supporter Kite
Twenty-year career fundraising expert to spearhead development initiatives for national blood cancer organization.
Frank Recruitment Group’s partnership will take place across all nine of their U.S.-based offices and the company will participate in LRF events and initiatives such as Lymphoma Walks, the Lymphoma Research Ride, Fundraise Your Way, Blood Cancer Awareness Month, and National Cancer Survivors Day.

On July 27, 2021, the Centers for Disease Control and Prevention (CDC) updated its Guidance for Fully Vaccinated people to include recommendations for those in the same household as immunocompromised people, including those with blood cancer.

The Lymphoma Scientific Research Mentoring Program (LSRMP) is a first-of-its-kind education and mentoring program for junior scientists who wish to focus on lymphoma clinical and laboratory/translational research.